MIR514A1: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker

Target Name: MIR514A1

NCBI ID: G574516

MIR514A1

MIR514A1: A Non-Coding RNA Molecule as A Potential Drug Target Or Biomarker

MIR514A1 (hsa-miR-514a-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a member of the miRNA-514a family, which is known for its role in regulating various cellular processes, including cell growth, apoptosis, and inflammation.

MIR514A1 is expressed in various tissues and cells, including the brain, heart, liver, and muscle. It has been shown to play a role in regulating cell proliferation and has been associated with the development of various diseases, including cancer.

One of the key functions of MIR514A1 is its ability to interact with the protein p21, which is a well-known regulator of cell growth and apoptosis. MIR514A1 has been shown to physically interact with p21 and can inhibit the activity of p21, leading to the stability of the protein and the inhibition of cell growth.

This interaction between MIR514A1 and p21 raises the possibility that MIR514A1 could be a drug target or biomarker for cancer. One approach to target MIR514A1 is to inhibit its interaction with p21 and increase its stability, leading to the apoptosis of cancer cells.

Another potential mechanism by which MIR514A1 could be used as a drug target is its role in the regulation of cell apoptosis. MIR514A1 has been shown to play a role in the regulation of cell apoptosis and has been associated with the development of various diseases, including cancer.

Studies have shown that MIR514A1 is expressed in various types of cancer, including breast, ovarian, and colorectal cancer. It has also been shown to be involved in the regulation of cell apoptosis in these cancer cells.

In addition to its potential role as a drug target or biomarker, MIR514A1 has also been shown to have potential utility as a diagnostic tool. The expression of MIR514A1 has been shown to be associated with the development of various diseases, including cancer.

This suggests that MIR514A1 could be a useful biomarker for the diagnosis and treatment of cancer. It is also worth noting that MIR514A1 has not yet been fully characterized, and more research is needed to fully understand its role in the regulation of cell growth and apoptosis.

In conclusion, MIR514A1 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its interaction with the protein p21 and its role in the regulation of cell apoptosis make it a promising candidate for targeting cancer cells. Further research is needed to fully understand its potential utility as a diagnostic tool and to identify its full role in the regulation of cell growth and apoptosis.

Protein Name: MicroRNA 514a-1

The "MIR514A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR514A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets